{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:49:27Z","timestamp":1783086567896,"version":"3.54.6"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphoedema is a common, distressing, and debilitating condition affecting more than 200 million people globally. There is a small body of evidence to guide lymphoedema care which underpins several lymphoedema clinical practice guidelines developed for high-income countries (HIC). Some of these recommendations are unlikely to be feasible in low-resource settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To develop practice points for healthcare workers that optimise lymphoedema care in low- and middle-income countries (LMIC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A nominal group technique (NGT) was undertaken to gain consensus on which content from HIC guidelines was important and feasible to include in practice points for LMIC, and other important advice or recommendations. Participants included experts, clinicians, and volunteers involved in lymphoedema care in LMIC. The NGT followed five key stages: silent \u2018ideas\u2019 generation, round-robin rationale, clarification, refinement and verification. The first, fourth and fifth stages were completed via email, and the second and third during a video meeting in order to generate a series of consensus based prevention, assessment, diagnosis, and management of lymphoedema in LMIC practice points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of sixteen participants invited, ten members completed stage 1 of the NGT (ideas generation), of whom six contributed to stages 2 (round-robin) and 3 (clarification). All those who completed stage 1 also completed stages 4 (refinement) and 5 (verification). Practice points unanimously agreed on included Complex Decongestive Therapy (CDT) and good skin care, with management to be determined by lymphoedema stage. For podoconiosis-endemic areas, the use of socks and shoes was identified as very important in the prevention of non-filarial lymphoedema and other lymphoedema-causing conditions. Participants indicated that diagnosing lymphoedema using the lymphoscintigraphy and Indocyanine green (ICG) fluorescent lymphography was not possible due to unavailability and cost in LMIC. Surgical procedures for lymphoedema management were unanimously eliminated due to the unavailability of technology, limited workforce, and expensive cost in LMIC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The consensus-based practice points generated by this project provide healthcare workers with guidance on caring for people with lymphoedema in LMIC. Further development of workforce capacity is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-023-09786-w","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T10:02:03Z","timestamp":1688810523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Practice points for lymphoedema care in low- and middle- income countries developed by nominal group technique"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1065-1718","authenticated-orcid":false,"given":"Eric","family":"Torgbenu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Luckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Buhagiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane L.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"issue":"1","key":"9786_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00428-016-1945-6","volume":"469","author":"LA Adamczyk","year":"2016","unstructured":"Adamczyk LA, Gordon K, Kholov\u00e1 I, Meijer-Jorna LB, Telinius N, Gallagher PJ, et al. Lymph vessels: the forgotten second circulation in health and disease. Virchows Archiv. 2016;469(1):3\u201317.","journal-title":"Virchows Archiv"},{"issue":"1","key":"9786_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.hsag.2015.08.003","volume":"21","author":"JE Maree","year":"2016","unstructured":"Maree JE, Beckmann D. \u201cJust live with it\u201d: Having to live with breast cancer related lymphoedema. Health SA Gesondheid. 2016;21(1):77\u201385.","journal-title":"Health SA Gesondheid"},{"issue":"5","key":"9786_CR3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jvsv.2019.02.015","volume":"7","author":"A Son","year":"2019","unstructured":"Son A, O\u2019Donnell TF Jr, Izhakoff J, Gaebler JA, Niecko T, Iafrati MA. Lymphoedema-associated comorbidities and treatment gap. J Vasc Surg Venous Lymphat Disord. 2019;7(5):724\u201330.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"9786_CR4","unstructured":"F\u00f6ldi M, F\u00f6ldi E, Str\u00f6\u00dfenreuther C, Kubik S. F\u00f6ldi's textbook of lymphology: for physicians and lymphedema therapists: Elsevier Health Sciences; 2012."},{"issue":"5","key":"9786_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/ecc.12311","volume":"24","author":"KD Cromwell","year":"2015","unstructured":"Cromwell KD, Chiang Y-J, Armer J, Heppner PP, Mungovan K, Ross MI, et al. Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema. Eur J Cancer Care. 2015;24(5):724\u201333.","journal-title":"Eur J Cancer Care"},{"issue":"2","key":"9786_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00520-012-1534-4","volume":"21","author":"JA Meiklejohn","year":"2013","unstructured":"Meiklejohn JA, Heesch KC, Janda M, Hayes SC. How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia. Support Care Cancer. 2013;21(2):459\u201366.","journal-title":"Support Care Cancer"},{"issue":"1","key":"9786_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13561-018-0194-6","volume":"8","author":"H Schulze","year":"2018","unstructured":"Schulze H, Nacke M, Gutenbrunner C, Hadamitzky C. Worldwide assessment of healthcare personnel dealing with lymphoedema. Heal Econ Rev. 2018;8(1):10.","journal-title":"Heal Econ Rev"},{"issue":"4","key":"9786_CR8","first-page":"170","volume":"49","author":"International Society of Lymphology","year":"2016","unstructured":"International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphology. Lymphology. 2016;49(4):170\u201384.","journal-title":"Lymphology"},{"issue":"9","key":"9786_CR9","doi-asserted-by":"publisher","first-page":"e1186","DOI":"10.1016\/S2214-109X(20)30286-2","volume":"8","author":"A Deshpande","year":"2020","unstructured":"Deshpande A, Miller-Petrie MK, Lindstedt PA, Baumann MM, Johnson KB, Blacker BF, et al. The global distribution of lymphatic filariasis, 2000\u201318: a geospatial analysis. Lancet Glob Health. 2020;8(9):e1186\u201394.","journal-title":"Lancet Glob Health"},{"key":"9786_CR10","unstructured":"World Health Organisation. Lymphatic filariasis 2021 [cited 2021 19 July]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lymphatic-filariasis. Accessed\u00a019 July 2021."},{"key":"9786_CR11","unstructured":"WHO. Lymphatic filariasis: reporting continued progress towards elimination as a public health problem Geneva2020 [Available from: https:\/\/www.who.int\/news\/item\/29-10-2020-lymphatic-filariasis-reporting-continued-progress-towards-elimination-as-a-public-health-problem. Accessed\u00a022 Nov 2021."},{"key":"9786_CR12","doi-asserted-by":"crossref","unstructured":"O'Donnell Jr TF, Allison GM, Iafrati MD. A systematic review of guidelines for lymphedema and the need for contemporary intersocietal guidelines for the management of lymphedema. J Vasc Surg Venous Lymphat Disord. 2020.","DOI":"10.1016\/j.jvsv.2020.03.006"},{"key":"9786_CR13","unstructured":"World Health Organisation. Wound and lymphoedema management. Geneva2010. Available from: https:\/\/www.who.int\/lymphatic_filariasis\/resources\/9789241599139\/en\/. Accessed\u00a09 June 2020."},{"key":"9786_CR14","doi-asserted-by":"crossref","unstructured":"Stout NL, Brantus P, Moffatt C. Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges. Global Public Health. 2012;7(2):107\u201323.","DOI":"10.1080\/17441692.2010.549140"},{"issue":"4","key":"9786_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009332","volume":"15","author":"A Tesfaye","year":"2021","unstructured":"Tesfaye A, Semrau M, Ali O, Kinfe M, Tamiru M, Fekadu A, et al. Development of an integrated, holistic care package for people with lymphoedema for use at the level of the Primary Health Care Unit in Ethiopia. PLoS Negl Trop Dis. 2021;15(4): e0009332.","journal-title":"PLoS Negl Trop Dis"},{"key":"9786_CR16","unstructured":"Cancer Australia. Recommendations and practice points 2022 [Available from: https:\/\/www.canceraustralia.gov.au\/resources\/clinical-practice-guidelines\/first-line-chemotherapy-treatment-women-epithelial-ovarian-cancer\/recommendations-and-practice-points. Accessed\u00a05 June 2020."},{"issue":"2","key":"9786_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1440-172X.2012.02017.x","volume":"18","author":"N Harvey","year":"2012","unstructured":"Harvey N, Holmes CA. Nominal group technique: an effective method for obtaining group consensus. Int J Nurs Pract. 2012;18(2):188\u201394.","journal-title":"Int J Nurs Pract"},{"issue":"1","key":"9786_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-016-0210-7","volume":"16","author":"NM Rankin","year":"2016","unstructured":"Rankin NM, McGregor D, Butow PN, White K, Phillips JL, Young JM, et al. Adapting the nominal group technique for priority setting of evidence-practice gaps in implementation science. BMC Med Res Methodol. 2016;16(1):1\u20139.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"9786_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/01411920120037117","volume":"27","author":"A MacPhail","year":"2001","unstructured":"MacPhail A. Nominal group technique: a useful method for working with young people. Br Edu Res J. 2001;27(2):161\u201370.","journal-title":"Br Edu Res J"},{"issue":"6","key":"9786_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/tri.12307","volume":"27","author":"MJ Irving","year":"2014","unstructured":"Irving MJ, Jan S, Tong A, Wong G, Craig JC, Chadban S, et al. What factors influence people\u2019s decisions to register for organ donation? The results of a nominal group study. Transpl Int. 2014;27(6):617\u201324.","journal-title":"Transpl Int"},{"issue":"3","key":"9786_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1467-842X.1997.tb01695.x","volume":"21","author":"S Redman","year":"1997","unstructured":"Redman S, Carrick S, Cockburn J, Hirst S. Consulting about priorities for the NHMRC National Breast Cancer Centre: how good is the nominal group technique. Aust N Z J Public Health. 1997;21(3):250\u20136.","journal-title":"Aust N Z J Public Health"},{"key":"9786_CR22","unstructured":"The World Bank Group. World Bank Country and Lending Groups 2019 [Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups. Accessed\u00a017 June 2019."},{"issue":"3","key":"9786_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/peps.12169","volume":"70","author":"B Marcus","year":"2017","unstructured":"Marcus B, Weigelt O, Hergert J, Gurt J, Gell\u00e9ri P. The use of snowball sampling for multi source organizational research: Some cause for concern. Pers Psychol. 2017;70(3):635\u201373.","journal-title":"Pers Psychol"},{"issue":"7","key":"9786_CR24","first-page":"749","volume":"3","author":"G Sharma","year":"2017","unstructured":"Sharma G. Pros and cons of different sampling techniques. Int J Appl Res. 2017;3(7):749\u201352.","journal-title":"Int J Appl Res"},{"issue":"1","key":"9786_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12885-020-07079-7","volume":"20","author":"E Torgbenu","year":"2020","unstructured":"Torgbenu E, Luckett T, Buhagiar MA, Chang S, Phillips JL. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis. BMC Cancer. 2020;20(1):604.","journal-title":"BMC Cancer"},{"issue":"1","key":"9786_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-022-07840-7","volume":"22","author":"E Torgbenu","year":"2022","unstructured":"Torgbenu E, Luckett T, Buhagiar M, Requena CM, Phillips JL. Improving care for cancer-related and other forms of lymphoedema in low-and middle-income countries: a qualitative study. BMC Health Serv Res. 2022;22(1):1\u201320.","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"9786_CR27","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/asi.20416","volume":"57","author":"LI Meho","year":"2006","unstructured":"Meho LI. E-mail interviewing in qualitative research: A methodological discussion. J Am Soc Inform Sci Technol. 2006;57(10):1284\u201395.","journal-title":"J Am Soc Inform Sci Technol"},{"issue":"3","key":"9786_CR28","first-page":"655","volume":"38","author":"SS McMillan","year":"2016","unstructured":"McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharm. 2016;38(3):655\u201362.","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"9786_CR29","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.12968\/bjcn.2006.11.Sup5.21974","volume":"11","author":"P Morgan","year":"2006","unstructured":"Morgan P, Moffatt C. An update on the Lymphoedema Framework Project. Br J Community Nurs. 2006;11(10):S20\u20131.","journal-title":"Br J Community Nurs"},{"issue":"5","key":"9786_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1188\/20.ONF.518-538","volume":"47","author":"JM Armer","year":"2020","unstructured":"Armer JM, Ostby PL, Ginex PK, Beck M, Deng J, Fu MR, et al. ONS guidelines\u2122 for Cancer Treatment-Related Lymphedema. Oncol Nurs Forum. 2020;47(5):518\u201338.","journal-title":"Oncol Nurs Forum"},{"key":"9786_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejogrb.2017.07.035","volume":"216","author":"N Gebruers","year":"2017","unstructured":"Gebruers N, Verbelen H, De Vrieze T, Vos L, Devoogdt N, Fias L, et al. Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: A best practice guideline. Eur J Obstet Gynecol Reprod Biol. 2017;216:245\u201353.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"9786_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10742-014-0121-1","volume":"14","author":"SS McMillan","year":"2014","unstructured":"McMillan SS, Kelly F, Sav A, Kendall E, King MA, Whitty JA, et al. Using the nominal group technique: how to analyse across multiple groups. Health Serv Outcomes Res Method. 2014;14:92\u2013108.","journal-title":"Health Serv Outcomes Res Method"},{"issue":"4","key":"9786_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0378-7206(95)00021-N","volume":"29","author":"ER Doke","year":"1995","unstructured":"Doke ER, Swanson NE. Decision variables for selecting prototyping in information systems development: a Delphi study of MIS managers. Inform Manag. 1995;29(4):173\u201382.","journal-title":"Inform Manag"},{"issue":"1","key":"9786_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2288-7-52","volume":"7","author":"EA Holey","year":"2007","unstructured":"Holey EA, Feeley JL, Dixon J, Whittaker VJ. An exploration of the use of simple statistics to measure consensus and stability in Delphi studies. BMC Med Res Methodol. 2007;7(1):52.","journal-title":"BMC Med Res Methodol"},{"key":"9786_CR35","unstructured":"The AGREE II Instrument [Electronic version]. [Internet]. 2017 [cited 10 October 2020]. Available from: http:\/\/www.agreetrust.org. Accessed\u00a010 Oct 2020."},{"key":"9786_CR36","unstructured":"Agency for Clinical Innovation Chronic Care Network. Lymphoedema: A guide for clinical services 2018 [Available from: https:\/\/www.aci.health.nsw.gov.au\/__data\/assets\/pdf_file\/0008\/477998\/lymphoedema-guide.pdf. Accessed\u00a030 Jan 2020."},{"key":"9786_CR37","unstructured":"Lee BB, Andrade M, Antignani PL, Boccardo F, Bunke N, Campisi C, et al. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2013. Int Angiol. 2013;32(6):541\u201374."},{"issue":"3","key":"9786_CR38","first-page":"E11","volume":"36","author":"M Perdomo","year":"2018","unstructured":"Perdomo M, Ryans K, Levenhagen K, Davies CC, Gilchrist L. Clinical implementation of the clinical practice guidelines for diagnosing upper-quadrant lymphedema secondary to cancer. Rehab Oncol. 2018;36(3):E11\u20138.","journal-title":"Rehab Oncol"},{"issue":"4","key":"9786_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/000331979404500408","volume":"34","author":"BB Lee","year":"2015","unstructured":"Lee BB, Antignani PL, Baroncelli TA, Boccardo FM, Brorson H, Campisi C, et al. IUA-ISVI consensus for diagnosis guideline of chronic lymphedema of the limbs. Int Angiol. 2015;34(4):311\u201332.","journal-title":"Int Angiol"},{"key":"9786_CR40","unstructured":"Clinical Resource Efficiency Support Team. Guidelines for the diagnosis, assessment and management of lymphoedema: Clinical Resource Efficiency Support Team; 2008."},{"issue":"5","key":"9786_CR41","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/heapol\/czab024","volume":"36","author":"K Manji","year":"2021","unstructured":"Manji K, Hanefeld J, Vearey J, Walls H, de Gruchy T. Using WhatsApp messenger for health systems research: a scoping review of available literature. Health Policy Plan. 2021;36(5):774\u201389.","journal-title":"Health Policy Plan"},{"key":"9786_CR42","unstructured":"Queensland Health. Queensland Health lymphoedema clinical practice guideline 2014 [Available from: https:\/\/www.health.qld.gov.au\/__data\/assets\/pdf_file\/0027\/146646\/guideline-lymph.pdf."},{"issue":"7","key":"9786_CR43","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/ptj\/pzaa087","volume":"100","author":"C Davies","year":"2020","unstructured":"Davies C, Levenhagen K, Ryans K, Perdomo M, Gilchrist L. Interventions for breast cancer-related lymphedema: clinical practice guideline from the academy of oncologic physical therapy of APTA. Phys Ther. 2020;100(7):1163\u201379.","journal-title":"Phys Ther"},{"issue":"2","key":"9786_CR44","first-page":"60","volume":"6","author":"K Kitamura","year":"2011","unstructured":"Kitamura K, Iwase S, Kuroda Y, Yamaguchi T, Yamamoto D, Odagiri H, et al. A practice guideline for the management of lymphoedema. J Lymphoedema. 2011;6(2):60\u201371.","journal-title":"J Lymphoedema"},{"issue":"2","key":"9786_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/14635240.2017.1415765","volume":"56","author":"SR Thompson","year":"2018","unstructured":"Thompson SR, Watson MC, Tilford S. The Ottawa Charter 30 years on: still an important standard for health promotion. Int J Health Promot Educ. 2018;56(2):73\u201384.","journal-title":"Int J Health Promot Educ"},{"key":"9786_CR46","first-page":"iii","volume":"1","author":"World Health Organization","year":"1986","unstructured":"World Health Organization. Ottawa charter for health promotion. Health Promot. 1986;1:iii\u2013v.","journal-title":"Health Promot"},{"issue":"10","key":"9786_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004171","volume":"9","author":"ME Stocks","year":"2015","unstructured":"Stocks ME, Freeman MC, Addiss DG. The effect of hygiene-based lymphedema management in lymphatic filariasis-endemic areas: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2015;9(10): e0004171.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"9786_CR48","first-page":"61","volume":"21","author":"J Nowicki","year":"2013","unstructured":"Nowicki J, Siviour A. Best practice skin care management in lymphoedema. Wound Pract Res J Austral Wound Manag Assoc. 2013;21(2):61\u20135.","journal-title":"Wound Pract Res J Austral Wound Manag Assoc"},{"key":"9786_CR49","doi-asserted-by":"crossref","unstructured":"Mahieu R, Krijger GC, Ververs FT, de Roos R, de Bree R, de Keizer B.\u00a0[68 Ga] Ga-tilmanocept PET\/CT\u00a0lymphoscintigraphy: a novel technique for sentinel lymph node imaging.\u00a0Eur J Nucl Med Mol Imaging.\u00a02021;48:963\u20135.\u00a0","DOI":"10.1007\/s00259-020-05101-5"},{"issue":"S8","key":"9786_CR50","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/cncr.27473","volume":"118","author":"AL Cheville","year":"2012","unstructured":"Cheville AL, Nyman JA, Pruthi S, Basford JR. Cost considerations regarding the prospective surveillance model for breast cancer survivors. Cancer. 2012;118(S8):2325\u201330.","journal-title":"Cancer"},{"issue":"7","key":"9786_CR51","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/s00520-019-05083-7","volume":"28","author":"BJ Svensson","year":"2020","unstructured":"Svensson BJ, Dylke ES, Ward LC, Black DA, Kilbreath SL. Screening for breast cancer\u2013related lymphoedema: self-assessment of symptoms and signs. Support Care Cancer. 2020;28(7):3073\u201380.","journal-title":"Support Care Cancer"},{"issue":"10","key":"9786_CR52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0169-4758(97)01130-7","volume":"13","author":"GJ Weil","year":"1997","unstructured":"Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today. 1997;13(10):401\u20134.","journal-title":"Parasitol Today"},{"key":"9786_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2021.105918","volume":"219","author":"S Wanji","year":"2021","unstructured":"Wanji S, Deribe K, Minich J, Debrah AY, Kalinga A, Kroidl I, et al. Podoconiosis-From known to unknown: Obstacles to tackle. Acta Trop. 2021;219: 105918.","journal-title":"Acta Trop"},{"issue":"7","key":"9786_CR54","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.bjps.2019.03.013","volume":"72","author":"GSA Phillips","year":"2019","unstructured":"Phillips GSA, Gore S, Ramsden A, Furniss D. Lymphaticovenular anastomosis in the treatment of secondary lymphoedema of the legs after cancer treatment. J Plast Reconstr Aesthet Surg. 2019;72(7):1184\u201392.","journal-title":"J Plast Reconstr Aesthet Surg"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09786-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-09786-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09786-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T10:03:32Z","timestamp":1688810612000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-09786-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9786"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-09786-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1877866\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,8]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies involving consensus process are not required to obtain ethics according to the National Statement on Ethical Conduct in Human Research developed jointly by the National Health and Medical Research Council, the Australian Research Council and Universities Australia. Consequently, projects building consensus among experts are not required to obtain formal ethical approval according to policy at the University of Technology Sydney provided participants agree to be identified on reports. It was made clear during recruitment that participation was voluntary, and that completion of Stage 1 and\/or attendance at the meeting for Stages 2 to 5 would be taken as evidence for consent. Participation included an understanding that names would be published, in accordance with common practice for consensus studies [\n                      \n                      ]. However, each participant\u2019s responses to the survey remained anonymous. Participants also reserved the right to discontinue participation at any time. These terms were repeated at commencement of the meeting. All methods were carried out in accordance with relevant guidelines and regulations, for example the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"740"}}